Delivery Order SPE2DB22D1017-SPE2DB25FF3ST

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,012.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566491539 METHYLPHENIDATE ER 36 MG TAB 100S, a prescription drug product, with a completion date of November 20, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,239.40 firm fixed-price delivery order is for the supply of METHYLPHENIDATE ER 36 MG TAB 100S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,696.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566743263 ! METHYLPHENIDATE ER 36 MG TAB 100S, a prescription medication, with a performance period ending on December 18, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award, valued at $1,781.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product, with a performance period ending on January 6, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,765.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564671979 - METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product, with a completion date of May 22, 2024. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,192.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564312406 - METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.41 firm fixed-price delivery order is for the supply of METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product. The award has an ultimate completion date of January 30, 2025 and is not designated as a set-aside procurement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $3,141.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of METHYLPHENIDATE ER 36 MG TAB 100S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,078.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product. The contract is not designated as a set-aside and is a firm fixed-price agreement with a completion date of January 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $1,224.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4564712987 ! METHYLPHENIDATE ER 36 MG TAB 100S, a medication, and has an ultimate completion date of May 28, 2024. This contract is a Delivery Order, with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating open...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF3ST
    Delivery Order

This federal contract award, valued at $1,288.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567024318 - METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product, with a completion date of January 24, 2025.

The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about major subcontractors. The DLA, as a defense agency, is responsible for providing supplies and services to the U.S. military and other government organizations, including medical products and pharmaceuticals.

Generated 4/24/25, 11:13 AM